← All indications
Leukemia, T-Cell
A malignant disease of the T-LYMPHOCYTES in the bone marrow, thymus, and/or blood.
Subtype terms (3)
More specific conditions that are subtypes of Leukemia, T-Cell in the MeSH hierarchy.
- Leukemia, Large Granular Lymphocytic
63 drugs (41 approved, 22 experimental)
- Leukemia-Lymphoma, Adult T-Cell
145 drugs (95 approved, 50 experimental)
- Leukemia, Prolymphocytic, T-Cell
35 drugs (22 approved, 13 experimental)
Drugs by status
Phase 3 trials (12)
Phase 2 trials (14)
Phase 1 trials (10)
Other trials (1)
Organizations
Organization Involved with Phase 4 Indications (1)
Organization Involved with Phase 3 Indications (12)
Organization Involved with Phase 2 Indications (50)
- Spectrum Pharmaceuticals
- Daiichi Sankyo
- Seattle Genetics
- Celgene
- BioCryst
- Merck
- Novartis
- Angimmune LLC
- Kyowa Hakko Kirin
- Otsuka
- National Institutes of Health (NIH)
- National Cancer Institute (NCI)
- National Heart, Lung, and Blood Institute (NHLBI)
- AIDS Malignancy Consortium
- Cancer and Leukemia Group B (CALGB)
- Case Western Reserve University
- Cornell University
- Eastern Cooperative Oncology Group
- Duke University
- University of Washington
- James Graham Brown Cancer Center
- Kumamoto University
- Northwestern University
- Ohio State University
- Okayama University
- Rutgers University
- Southwest Oncology Group
- Stanford University
- Sichuan University
- Thomas Jefferson University
- +20 more
Organization Involved with Phase 1 Indications (23)
- Millennium Pharmaceuticals
- Amgen
- Morphotek
- Arno Therapeutics
- Erimos Pharmaceuticals
- miRagen Therapeutics, Inc.
- University of Pittsburgh
- Central South University
- Johns Hopkins University
- Kunming Medical University
- Wake Forest University
- Wayne State University
- Chongqing Medical University
- Fujian Medical University
- Stony Brook University
- University of Colorado, Denver
- Jiao Tong University
- University of Wisconsin
- University of Alabama, Birmingham
- Guizhou Medical University
- People's Liberation Army of China
- Gracell Biotechnology Ltd.
- iCell Gene Therapeutics
Organization Involved with Other Experimental Indications (1)